Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
Tien V. Nguyen, Giovanni Damiani, Lauren A.V. Orenstein, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 1, pp. 50-61
Closed Access | Times Cited: 272

Showing 1-25 of 272 citing articles:

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
Alexa B. Kimball, Gregor B. E. Jemec, Christopher Sayed, et al.
The Lancet (2024) Vol. 403, Iss. 10443, pp. 2504-2519
Closed Access | Times Cited: 59
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study
Fabrizio Martora, Claudio Marasca, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 159-166
Open Access | Times Cited: 23
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial
Afsáneh Alavi, Errol P. Prens, Alexa B. Kimball, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 508-518
Open Access | Times Cited: 16
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies*
Afsáneh Alavi, Iltefat Hamzavi, Kurt Brown, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 5, pp. 803-813
Open Access | Times Cited: 66
The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis
Trinidad Montero‐Vílchez, Pablo Díaz‐Calvillo, Juan-Ángel Rodríguez-Pozo, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 6709-6709
Open Access | Times Cited: 60
New and Emerging Targeted Therapies for Hidradenitis Suppurativa
Adela Markota Čagalj, Branka Marinović, Zrinka Bukvić Mokoš
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3753-3753
Open Access | Times Cited: 55
Insights into hidradenitis suppurativa
Kelsey R. van Straalen, Errol P. Prens, Jóhann E. Guðjónsson
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 4, pp. 1150-1161
Closed Access | Times Cited: 46
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
Helena Iznardo, L. Puig
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9479-9479
Open Access | Times Cited: 43
Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies
Stephanie L Schell, Zhaoyuan Cong, Mackenzie L. Sennett, et al.
British Journal of Dermatology (2022) Vol. 188, Iss. 3, pp. 407-419
Closed Access | Times Cited: 40
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study
Ludovica Verde, Sara Cacciapuoti, Giuseppina Caiazzo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
New-Onset Hidradenitis Suppurativa in Psoriasis Patients: A Multi-Center, Retrospective Cohort Study
Chen-Pi Li, Shao‐Wei Lo, Ru‐Yin Tsai, et al.
Life (2024) Vol. 14, Iss. 6, pp. 730-730
Open Access | Times Cited: 11
Deroofing: A safe, effective and well‐tolerated procedure in patients with hidradenitis suppurativa
Piotr Krajewski, V. Sanz‐Motilva, S. Flores Martinez, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 5, pp. 931-936
Closed Access | Times Cited: 9
Causal relationship between gut microbiota and hidradenitis suppurativa: a two-sample Mendelian randomization study
Chengling Liu, Xingchen Liu, Xin Li
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life
Donald E. Greydanus, Roua Azmeh, Maria Demma Cabral, et al.
Disease-a-Month (2020) Vol. 67, Iss. 4, pp. 101103-101103
Closed Access | Times Cited: 50
New perspectives on the treatment of hidradenitis suppurativa
Victòria Amat‐Samaranch, Eugènia Agut‐Busquet, Eva Vilarrasa, et al.
Therapeutic Advances in Chronic Disease (2021) Vol. 12
Open Access | Times Cited: 49
Top Advances in Dermatologic Ultrasound
Ximena Wortsman
Journal of Ultrasound in Medicine (2022) Vol. 42, Iss. 3, pp. 521-545
Closed Access | Times Cited: 36
Citation analysis of the 100 top-cited articles on the topic of hidradenitis suppurativa since 2013 using Sankey diagrams: Bibliometric analysis
Ting-Ya Yang, Tsair‐Wei Chien, Feng‐Jie Lai
Medicine (2022) Vol. 101, Iss. 44, pp. e31144-e31144
Open Access | Times Cited: 30
Hidradenitis Suppurativa Burdens on Mental Health: A Literature Review of Associated Psychiatric Disorders and Their Pathogenesis
Stefano Caccavale, Vittorio Tancredi, Maria Pia Boccellino, et al.
Life (2023) Vol. 13, Iss. 1, pp. 189-189
Open Access | Times Cited: 18
Hidradenitis Suppurativa
Toni Jenkins, Jahdonna Isaac, Alicia Edwards, et al.
Dermatologic Clinics (2023) Vol. 41, Iss. 3, pp. 471-479
Closed Access | Times Cited: 18
Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management
Corey L. Snyder, Stella Chen, Martina L. Porter
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1833-1841
Open Access | Times Cited: 17
Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large‐scale, propensity‐matched global retrospective cohort study
Piotr Krajewski, Łukasz Matusiak, Sascha Ständer, et al.
International Journal of Dermatology (2024) Vol. 63, Iss. 6, pp. 799-805
Closed Access | Times Cited: 8
Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa
Nikolaj Holgersen, Valdemar Wendelboe Nielsen, Nana Aviaaja Lippert Rosenø, et al.
JAAD International (2024) Vol. 15, pp. 170-178
Open Access | Times Cited: 6
Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management
Rabia Arshad, Iqra Fatima, Saman Sargazi, et al.
Nanomaterials (2021) Vol. 11, Iss. 12, pp. 3330-3330
Open Access | Times Cited: 40
Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects
Dillon Mintoff, Farida Benhadou, Nikolai Paul Pace, et al.
International Journal of Dermatology (2021) Vol. 61, Iss. 10, pp. 1175-1186
Closed Access | Times Cited: 36
Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa
Stephanie L Schell, Andreá Schneider, Amanda M. Nelson
Experimental Dermatology (2021) Vol. 30, Iss. 10, pp. 1453-1470
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top